Self-sampling for Non-attenders to Cervical Cancer Screening
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age30-65
SponsorThe Institute of Molecular and Translational Medicine, Czech Republic
About this trial
The trial will evaluate whether self-sampling and human papillomavirus (HPV) testing may increase cervical cancer screening attendance among under-screened women in Czech Republic. Different ways of offering self-sampling device will be evaluated.
Eligibility criteria
Qualifiers
Women with age 30-65 years; for arm A women > 65 years are allowed
Women live in the Czech Republic.
Women who have not participate in cervical cancer screening program in the Czech Republic for at least 3 years (Arm B and C).
Women with completed informed consent.
Disqualifiers
Pregnant women.
Women with no sexual intercourse experience.
Women after hysterectomy including cervix.
Trial design
Treatments tested in this trial
- Self-sampling by Evalyn Brush
- Self sampling by Evalyn Brush home or in GP´s clinic
Treatment groups
15,000 Participants
are divided into 3 treatment groupsSponsors and collaborators
The Institute of Molecular and Translational Medicine, Czech Republic
Lead sponsor
National Institute for Cancer Research, Czech Republic
Collaborator
Source ClinicalTrials.gov